Parke Davis PharmaceuticalsPharmaceutical Sales Representative
Jan. 1998 - Jan. 2003Detailed diabetic, cholesterol, hypertensive, and neurological products to internal medicine, family practice physicians, cardiologists, and psychiatrists in El Paso and southern New Mexico. Was a part of the product launch for the anti-depressant Celexa in this market. Increased market share with Lipitor and Celexa and maintained continual growth with Rezulin even during the FDA removal discussions. Placed 8 out of 67 in a Rezulin increasing market share contest